Peter Buehlmayer

Title: The Innovations of Peter Buehlmayer

Introduction

Peter Buehlmayer is a notable inventor based in Arlesheim, Switzerland. He has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. His work primarily focuses on the development of innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Buehlmayer has developed new salts of valsartan, which include crystalline, partly crystalline, and amorphous forms. This invention details the production and usage of these salts, as well as pharmaceutical preparations that incorporate them. Another significant patent involves bicyclic heteroaryl cycloalkyldiamine derivatives, which are designed to act as SYK inhibitors. This patent outlines the processes for their production and the pharmaceutical compositions that include these derivatives.

Career Highlights

Throughout his career, Peter Buehlmayer has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has allowed him to contribute to various innovative projects and advancements in drug development.

Collaborations

Buehlmayer has collaborated with several professionals in his field, including Klaus Hinterding and Gebhard Thoma. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Peter Buehlmayer's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of chemical compounds and their potential applications in healthcare.